Salim Syed
Stock Analyst at Mizuho Securities
(0.92)
# 3,698
Out of 4,357 analysts
1083
Total ratings
42.5%
Success rate
-0.8%
Average return
Main Sectors:
Stocks Rated by Salim Syed
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IPSC Century Therapeutics | Initiated Coverage: Buy | $8 | $2.36 | +238.98% | 1 | May 27, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $106 | $65.36 | +62.18% | 105 | Apr 28, 2026 | |
| NKTX Nkarta | Maintained: Buy | $14 → $12 | $3.14 | +282.17% | 41 | Mar 31, 2026 | |
| ATRA Atara Biotherapeutics | Maintained: Buy | $18 | $10.28 | +75.10% | 80 | Mar 30, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $45 → $43 | $18.85 | +128.12% | 8 | Mar 30, 2026 | |
| AUTL Autolus Therapeutics | Rated: Buy | $12 → $10 | $1.84 | +443.48% | 5 | Mar 30, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $97 | $25.46 | +280.99% | 3 | Mar 30, 2026 | |
| ASMB Assembly Biosciences | Maintained: Buy | $40 | $26.92 | +48.59% | 39 | Mar 24, 2026 | |
| KURA Kura Oncology | Rated: Buy | $30 → $25 | $9.04 | +176.70% | 8 | Mar 24, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $22 → $27 | $6.26 | +331.31% | 79 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 → $45 | $37.51 | +19.97% | 16 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $84 → $100 | $73.68 | +35.72% | 145 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $170 | $131.10 | +29.67% | 110 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $280 → $295 | $329.13 | -10.37% | 169 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $207 → $236 | $192.23 | +22.77% | 131 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $90 → $121 | $95.59 | +26.58% | 6 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $163 | $48.91 | +233.27% | 22 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.74 | +191.97% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $25.67 | +75.30% | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $54.19 | n/a | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.96 | n/a | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $115.17 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.80 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $25.63 | n/a | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $3.91 | n/a | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.57 | n/a | 73 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $11.75 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $55.03 | n/a | 1 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $21.84 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.1 | $13.83 | n/a | 1 | Jul 2, 2019 |
Century Therapeutics
May 27, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $2.36
Upside: +238.98%
BridgeBio Pharma
Apr 28, 2026
Maintained: Buy
Price Target: $106
Current: $65.36
Upside: +62.18%
Nkarta
Mar 31, 2026
Maintained: Buy
Price Target: $14 → $12
Current: $3.14
Upside: +282.17%
Atara Biotherapeutics
Mar 30, 2026
Maintained: Buy
Price Target: $18
Current: $10.28
Upside: +75.10%
Syndax Pharmaceuticals
Mar 30, 2026
Maintained: Buy
Price Target: $45 → $43
Current: $18.85
Upside: +128.12%
Autolus Therapeutics
Mar 30, 2026
Rated: Buy
Price Target: $12 → $10
Current: $1.84
Upside: +443.48%
Maze Therapeutics
Mar 30, 2026
Maintained: Buy
Price Target: $97
Current: $25.46
Upside: +280.99%
Assembly Biosciences
Mar 24, 2026
Maintained: Buy
Price Target: $40
Current: $26.92
Upside: +48.59%
Kura Oncology
Mar 24, 2026
Rated: Buy
Price Target: $30 → $25
Current: $9.04
Upside: +176.70%
Wave Life Sciences
Mar 24, 2026
Maintained: Buy
Price Target: $22 → $27
Current: $6.26
Upside: +331.31%
Mar 24, 2026
Maintained: Buy
Price Target: $41 → $45
Current: $37.51
Upside: +19.97%
Mar 18, 2026
Rated: Buy
Price Target: $84 → $100
Current: $73.68
Upside: +35.72%
Feb 19, 2026
Maintained: Buy
Price Target: $140 → $170
Current: $131.10
Upside: +29.67%
Feb 11, 2026
Maintained: Hold
Price Target: $280 → $295
Current: $329.13
Upside: -10.37%
Feb 11, 2026
Maintained: Buy
Price Target: $207 → $236
Current: $192.23
Upside: +22.77%
Dec 8, 2025
Upgraded: Buy
Price Target: $90 → $121
Current: $95.59
Upside: +26.58%
Nov 20, 2025
Maintained: Buy
Price Target: $163
Current: $48.91
Upside: +233.27%
Nov 14, 2025
Maintained: Buy
Price Target: $8
Current: $2.74
Upside: +191.97%
Aug 18, 2025
Maintained: Buy
Price Target: $45
Current: $25.67
Upside: +75.30%
May 20, 2025
Maintained: Buy
Price Target: $85
Current: $54.19
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $10
Current: $3.96
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $115.17
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $11.80
Upside: n/a
May 28, 2024
Maintained: Buy
Price Target: $53
Current: $25.63
Upside: n/a
Mar 25, 2024
Maintained: Buy
Price Target: $25
Current: $3.91
Upside: n/a
Jun 16, 2023
Rated: Hold
Price Target: n/a
Current: $1.57
Upside: n/a
Mar 6, 2023
Maintained: Buy
Price Target: $21
Current: $11.75
Upside: n/a
Nov 3, 2022
Maintained: Buy
Price Target: $23
Current: $55.03
Upside: n/a
Aug 4, 2022
Maintained: Buy
Price Target: $25
Current: $21.84
Upside: n/a
Jul 2, 2019
Maintained: Buy
Price Target: $7.1
Current: $13.83
Upside: n/a